In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains
- PMID: 16551496
- DOI: 10.1016/j.ijpharm.2006.02.017
In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains
Abstract
Twelve lipid formulations of liposomal meropenem were tested on six drug-susceptible and two drug-resistant Pseudomonas aeruginosa strains to determine their antibacterial activity. Cationic liposomes, especially PC/DOPE/SA 4:4:2 and PC/DOTAP/Chol 5:2:3, were more effective than anionic ones against sensitive isolates as the MICs of those formulations were two to four times lower than those of the free drug. None of the studied liposomal forms of meropenem exhibited bactericidal activity against isolates, which are drug-resistant due to low permeability. Even Fluidosomes (liposomes made of DPPC/DMPG 18:1), which demonstrated fusion with P. aeruginosa membranes, showed 4-16 times higher MICs for sensitive and resistant strains than did the free meropenem.
Similar articles
-
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.Int J Pharm. 2008 May 1;355(1-2):293-8. doi: 10.1016/j.ijpharm.2007.11.035. Epub 2007 Nov 24. Int J Pharm. 2008. PMID: 18164881
-
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.Int J Antimicrob Agents. 2006 Mar;27(3):247-52. doi: 10.1016/j.ijantimicag.2005.10.021. Epub 2006 Feb 10. Int J Antimicrob Agents. 2006. PMID: 16472992
-
Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.J Antimicrob Chemother. 2005 Feb;55(2):269-71. doi: 10.1093/jac/dkh518. Epub 2004 Dec 8. J Antimicrob Chemother. 2005. PMID: 15590716
-
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S100-5. doi: 10.1086/504487. Clin Infect Dis. 2006. PMID: 16894511 Review.
-
Liposomes as drug carriers in the therapy of infectious diseases.Horiz Biochem Biophys. 1989;9:249-79. Horiz Biochem Biophys. 1989. PMID: 2656478 Review. No abstract available.
Cited by
-
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms.Pharmaceutics. 2016 May 24;8(2):18. doi: 10.3390/pharmaceutics8020018. Pharmaceutics. 2016. PMID: 27231933 Free PMC article. Review.
-
A comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicin.Cell Mol Biol Lett. 2006;11(3):360-75. doi: 10.2478/s11658-006-0030-6. Cell Mol Biol Lett. 2006. PMID: 16847556 Free PMC article.
-
Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics.Front Bioeng Biotechnol. 2021 Jul 8;9:696514. doi: 10.3389/fbioe.2021.696514. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34307323 Free PMC article. Review.
-
Nanobiosystems for Antimicrobial Drug-Resistant Infections.Nanomaterials (Basel). 2021 Apr 22;11(5):1075. doi: 10.3390/nano11051075. Nanomaterials (Basel). 2021. PMID: 33922004 Free PMC article. Review.
-
Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?Int J Nanomedicine. 2024 Apr 29;19:3861-3890. doi: 10.2147/IJN.S445955. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38708178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources